Foghorn Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Foghorn Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Foghorn Therapeutics Inc
Rating: 1.34666675
Author: Trendlyne DVM scores

about

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, ...

5.65 0.16 (2.91%)

92.18% Gain from 52W Low

107.6K

XNAS Volume

XNAS 11 Mar, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Foghorn Therapeutics Inc is on 13 Mar 2026 for the purpose of Foghorn Therapeutics Inc Fourth Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

6.2 / 100

Technically Neutral

47.7 / 100

1Yr Price target upside is 102%

9 analysts

Foghorn Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Foghorn Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, ...

92.18% Gain from 52W Low

SWOT Analysis

Foghorn Therapeutics Inc Live Price Chart